Cargando…

The Use of a Hybrid Closed-Loop System for Glycemic Control in Two Pediatric Patients with Type 1 Diabetes Undergoing Minor Surgery

Technological progress in the treatment of type 1 diabetes requires doctors to use modern methods of insulin therapy in all areas of medicine that patients may come into contact with, including surgical interventions. The current guidelines indicate the possibility of using continuous subcutaneous i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seget, Sebastian, Włodarczyk, Julia, Lutogniewska, Wanda, Rusak, Ewa, Dróżdż, Maria, Jarosz-Chobot, Przemysława
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957216/ https://www.ncbi.nlm.nih.gov/pubmed/36833120 http://dx.doi.org/10.3390/healthcare11040587

Ejemplares similares

Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022
por: Seget, Sebastian, et al.
Publicado: (2023)

Prospective Open-Label, Single-Arm, Single-Center Follow-Up Study of the Application of the Advanced Hybrid Closed Loop System in Well-Controlled Children and Adolescents with Type 1 Diabetes
por: Seget, Sebastian, et al.
Publicado: (2022)

Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
por: Seget, Sebastian, et al.
Publicado: (2022)

Can the AHCL System Be Used in T1D Patients with Borderline TDDI? A Case Report
por: Tekielak, Anna, et al.
Publicado: (2021)

Has the COVID-19 Pandemic Affected the Prevalence of Diabetic Ketoacidosis in Polish Children with Newly Diagnosed Type 1 Diabetes? An Example of the Largest Polish Pediatric Diabetes Center (Upper Silesia—Katowice, Poland)
por: Rusak, Ewa, et al.
Publicado: (2022)

The Quality of Life and Satisfaction with Continuous Glucose Monitoring Therapy in Children under 7 Years of Age with T1D Using the rtCGM System Integrated with Insulin Pump—A Caregivers Point of View
por: Rusak, Ewa, et al.
Publicado: (2021)

Nutrition analysis – with particular focus on carbohydrate content in kefirs and natural yoghurts in the Polish consumer market
por: Mańkiewicz-Żurawska, Irena, et al.
Publicado: (2023)

The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
por: Noras, Katarzyna, et al.
Publicado: (2021)

Bacterial strains colonizing the sensor electrodes of a continuous glucose monitoring system in children with diabetes
por: Seget, Sebastian, et al.
Publicado: (2020)

The role and need for psychological support in the treatment of adolescents and young people suffering from type 1 diabetes
por: Małachowska, Magdalena, et al.
Publicado: (2023)

Type 1 diabetes in an adolescent with social problems and mental disorders – case report
por: Grobelczyk, Agnieszka, et al.
Publicado: (2021)

Reference Ranges of Glycemic Variability in Infants after Surgery—A Prospective Cohort Study
por: Kaminska, Halla, et al.
Publicado: (2022)

Obesity and diabetes—Not only a simple link between two epidemics
por: Chobot, Agata, et al.
Publicado: (2018)

Severe malnutrition as a cause of transient carbohydrate metabolism disorders which evolved into hyperosmolar hyperglycaemic state
por: Sokołowska-Gadoux, Magdalena, et al.
Publicado: (2022)

Introduction to the Polish branch of the INNODIA program
por: Pokrywka, Paulina, et al.
Publicado: (2023)

Thyroid diseases – ally or enemy of type 1 diabetes in children and adolescents?
por: Ogarek, Natalia, et al.
Publicado: (2021)

Is the Association Between TNF-α-308 A Allele and DMT1 Independent of HLA-DRB1, DQB1 Alleles?
por: Deja, Grażyna, et al.
Publicado: (2006)

Body mass index and partial remission in 119 children with type 1 diabetes—a 6-year observational study
por: Sokołowska-Gadoux, Magdalena, et al.
Publicado: (2023)

The Assessment of Autoimmunological Status and Prevalence of Different Forms of Celiac Disease among Children with Type 1 Diabetes Mellitus and Celiac Disease
por: Deja, Grazyna, et al.
Publicado: (2008)

Glucose management indicator – potential factors affecting differences in comparison with HbA1c and clinical significance of this phenomenon
por: Wybrańczyk, Łukasz, et al.
Publicado: (2023)

The Stricter the Better? The Relationship between Targeted HbA(1c) Values and Metabolic Control of Pediatric Type 1 Diabetes Mellitus
por: Braun, Marcin, et al.
Publicado: (2016)

Assessment of optimal insulin administration timing for standard carbohydrates‐rich meals using continuous glucose monitoring in children with type 1 diabetes: A cross‐over randomized study
por: Tucholski, Krzysztof, et al.
Publicado: (2019)

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
por: Pozzilli, Paolo, et al.
Publicado: (2015)

The Usefulness of Genotyping of Celiac Disease-Specific HLA among Children with Type 1 Diabetes in Various Clinical Situations
por: Deja, Grazyna, et al.
Publicado: (2020)

Oral microbiota in children with type 1 diabetes mellitus
por: Pachoński, Marek, et al.
Publicado: (2021)

Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes
por: Gawrecki, Andrzej, et al.
Publicado: (2021)

Atherosclerosis: risk assessment and the role of aiming for optimal glycaemic control in young patients with type 1 diabetes
por: Kolasa, Martyna, et al.
Publicado: (2022)

Training and Support for Hybrid Closed-Loop Therapy
por: Boughton, Charlotte K., et al.
Publicado: (2020)

Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
por: Cordero, Toni L., et al.
Publicado: (2023)

Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery
por: Malone, Susan Kohl, et al.
Publicado: (2021)

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
por: Carlson, Anders L., et al.
Publicado: (2022)

L-thyroxine Stabilizes Autoimmune Inflammatory Process in Euthyroid Nongoitrous Children with Hashimoto’s Thyroiditis and Type 1 Diabetes Mellitus
por: Korzeniowska, Katarzyna, et al.
Publicado: (2013)

Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
por: Longo, Miriam, et al.
Publicado: (2020)

Advanced Hybrid Closed Loop users’ satisfaction of telemedicine and telenursing in pediatric and young adult type 1 diabetes
por: Bassi, Marta, et al.
Publicado: (2023)

Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery
por: Krutkyte, Gabija, et al.
Publicado: (2023)

The Empowerment of Adolescents with Type 1 Diabetes Is Associated with Their Executive Functions
por: Łuczyński, Włodzimierz, et al.
Publicado: (2019)

Markers of Anemia in Children with Type 1 Diabetes
por: Rusak, Ewa, et al.
Publicado: (2018)

Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy?
por: Lendínez-Jurado, Alfonso, et al.
Publicado: (2023)

Impact on glucometric variables and quality of life of the advanced hybrid closed‐loop system in pediatric and adolescent type 1 diabetes
por: Lendínez‐Jurado, Alfonso, et al.
Publicado: (2023)

Medtronic MiniMed 670G Hybrid Closed-Loop System
por: Knebel, Tory, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ofutmljtvn5a5jsm08tufk0ej7